Puneet Sharma, MD
Interventional Cardiology · Fargo, NDNPI 1184808354
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,625 of the $7,351 with a category attached, or 62.9%. 14 manufacturers reported payments, led by Edwards Lifesciences at 31.7% of the total. Reporting peaked in 2021 at $2,197 and has fallen 95.8% since, to $93 in 2025.
Across 60 payments — averaging $122.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2K
- Abbott$2K
- Livanova USA, Inc.$779
- Baylis Medical Company Inc$666
- Medtronic$534
- W. L. Gore & Associates, Inc.$487
- plus $988 from 8 others
What the payments were for
- Travel & lodging$4,62563%
- Food & beverage$2,61136%
- Education$1152%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 16 | $2,333 |
| Abbott | 13 | $1,563 |
| Livanova USA, Inc. | 4 | $779 |
| Baylis Medical Company Inc | 5 | $666 |
| Medtronic(2 entities) | 9 | $534 |
| W. L. Gore & Associates, Inc. | 4 | $487 |
| Artivion, Inc. | 1 | $404 |
| Abiomed | 1 | $235 |
| Boston Scientific | 2 | $107 |
| Shockwave Medical, Inc | 1 | $104 |
| AstraZeneca | 1 | $100 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Novartis | 1 | $12 |
| Cardiovascular Systems Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,674
- AMPLATZER Occluders$1,265
- TandemLife$714
- VersaCross Access Solution$520
- On-X$404
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$319
- Impella$235
- CoreValve Evolut$138
- SYMPLICITY G3$129
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$108
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$104
- CARDIOMEMS$102
How this compares
Too few interventional cardiology providers in North Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 76 | $54,388 |
| XareltoRivaroxaban | 38 | $29,683 |
| Enoxaparin Sodium | 43 | $3,518 |
| Metoprolol Succinate | 141 | $2,692 |
| Warfarin Sodium | 133 | $1,437 |
| JantovenWarfarin Sodium | 103 | $1,130 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 50 | $806 |
| Losartan Potassium | 74 | $601 |
| Atorvastatin Calcium | 33 | $512 |
| Lisinopril | 75 | $429 |
| Rosuvastatin Calcium | 25 | $350 |
| Metoprolol Tartrate | 35 | $327 |
| Torsemide | 12 | $275 |
| Amlodipine Besylate | 52 | $247 |
| ClopidogrelClopidogrel Bisulfate | 19 | $224 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Fargo
- Alok SauravFargo$10K
- Yassar AlmanaseerFargo$7K
- Ismail BekdashFargo$6K
- Rory FarnanFargo$6K
- Nayan DesaiBismarck$413K
- Hai XuBismarck$25K
- Jared SteinbergerBismarck$9K
- Yara Letitia CameronGrand Forks$8K
- Camelia IlieBismarck$1K
- John HoytBismarck$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.